1-4 of 4
Susanne Marschner, Ph.D.
Close
Sort by
Journal Articles

Impact of Pathogen Reduction Technology Treatment and Storage in New Generation Platelet Additive Solutions (PAS) on Platelet Function.

Gines Escolar, MD, PhD, Miguel Lozano, MD, PhD, Patricia Molina, Susanne Marschner, Ph.D., Raymond Goodrich, PhD, Ana M. Galan, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2115.
https://doi.org/10.1182/blood.V114.22.2115.2115
Published: 2009
Journal Articles

Inactivation of Human Leukocytes in Platelet Products After Pathogen Reduction Technology Treatment in the Presence of Platelet Additive Solution.

Loren D. Fast, PhD, Susanne Marschner, Ph.D., Gilbert DiLeone, Ph.D., Raymond Goodrich, PhD
Journal: Blood
Blood (2009) 114 (22): 2116.
https://doi.org/10.1182/blood.V114.22.2116.2116
Published: 2009
Journal Articles

Inactivation of Human White Blood Cells in Red Blood Cell Products Using the MIRASOL® System for Whole Blood.

Loren D. Fast, PhD, Susanne Marschner, Ph.D., Gilbert DiLeone, Ph.D., Suzann Doane, B.S., Christy Fitzpatrick, B.S., Goodrich Ray, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2897.
https://doi.org/10.1182/blood.V110.11.2897.2897
Published: 2007
Journal Articles

Inactivation of Human White Blood Cells in Red Blood Cell Products Using Mirasol® Pathogen Reduction Technology (PRT).

Loren D. Fast, PhD, Susanne Marschner, Ph.D., Gilbert DiLeone, Ph.D., Suzann K. Doane, B.S., Raymond P. Goodrich, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4135.
https://doi.org/10.1182/blood.V108.11.4135.4135
Published: 2006